METTL16 and urinary bladder carcinoma: To our knowledge, this is the first comprehensive study to verify that METTL16 may regulate the progression of bladder cancer in an m6A-dependent manner and it is also the first to explore the possible regulatory mechanisms upstream of METTL16 in solid tumors.